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Abstract The FYVE zinc finger domain is conserved from yeast
(five proteins) to man (27 proteins). It functions in the membrane
recruitment of cytosolic proteins by binding to phosphatidylino-
sitol 3-phosphate (PI3P), which is found mainly on endosomes.
Here we review recent work that sheds light on the targeting
of FYVE finger proteins to PI3P-containing membranes,
and how these proteins serve to regulate multiple cellular
functions. ß 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Phosphoinositides, phosphorylated derivatives of phospha-
tidylinositol, function as spatial regulators of crucial cellular
processes by recruiting cytosolic proteins to speci¢c mem-
brane compartments [1]. Among the most ubiquitous phos-
phoinositides is phosphatidylinositol 3-phosphate (PI3P),
which is generated from phosphatidylinositol by speci¢c iso-
forms of phosphatidylinositol 3-kinase (PI3K). Even though
the levels of PI3P are low (typically 0.2% of phosphatidylino-
sitol in mammalian cells), this phosphoinositide is crucial for
endocytic membrane tra⁄cking and other cellular functions.
The localisation of PI3P to endosomes and yeast vacuoles [2]
suggests that it functions by recruiting e¡ector proteins to
these membranes. Two distinct protein domains have been
found to bind to PI3P with high a⁄nity and speci¢city. One
is the Phox homology (PX) domain, which is found in pro-
teins that regulate the NADPH oxidase complex, cell survival,
and endocytic membrane tra⁄cking [3,4]. The other is the
FYVE ¢nger (zinc ¢nger originally observed in Fab1p,
YOTB, Vac1p and EEA1) [5], which is the topic of this re-
view. We here discuss the biological role of the FYVE ¢nger
in the light of recently accomplished genome sequences, struc-
tural determinations and functional data.
2. FYVE ¢nger proteins in the human, nematode and yeast
proteomes
Using database searches we ¢nd a total of 27 FYVE ¢nger
proteins in the human proteome (Fig. 1 and Table 1). This is
close to the number reported for the human genome (28) [6],
whereas the SMART system [7] reports as many as 48 human
FYVE ¢nger proteins. The discrepancy is probably due to a
weaker criterion used by SMART, as some of the SMART
hits actually represent RING ¢ngers, and SMART also con-
tains some redundant sequences. For Caenorhabditis elegans,
we ¢nd 13 FYVE ¢nger proteins (Table 1), while 15 were
reported in the C. elegans genome [6]. Again, this is probably
due to di¡erent criteria for distinguishing between FYVE ¢n-
gers and FYVE-related ¢ngers. In addition, there appears to
be additional proteins in C. elegans with distantly related zinc
¢nger domains. In Saccharomyces cerevisiae, ¢ve FYVE ¢nger
proteins can be identi¢ed. The number of FYVE ¢nger pro-
teins found in humans, nematodes and yeast thus correlates
well with the total estimated numbers of genes in these organ-
isms (42 000, 18 000 and 6000, respectively).
As illustrated by the alignment (Fig. 1), all zinc-coor-
dinating cysteines are absolutely conserved in human
FYVE ¢ngers. Apart from the coordinating residues, the
R+HHCRxCG motif (in single-letter amino acid code; x
means any amino acid) involved in ligand binding (see below)
is the most conspicuous feature of the alignment. Additional
conserved sequence elements are an N-terminal WxxD motif,
and a C-terminal RCV motif, which are both involved in li-
gand binding (see below). Except for the zinc coordinators,
glycine-39 in the alignment is the only residue that is fully
conserved in all FYVE ¢ngers. This glycine is positioned at
the beginning of L-strand 2, and it presumably plays a critical
role in forming the core fold of the domain. It is worth noting
that this residue is not conserved in Rabphilin-3A and other
FYVE-related zinc ¢ngers [8]. Two of the domains (FENS-1
and MGC20275) have small insertions N-terminal to the ¢rst
L-strand. Interestingly, both these proteins have a glutamine
in position 32 of the alignment, instead of the conserved ar-
ginine/lysine. Rabenosyn-5 has a 42-residue insertion after the
third L-strand, and its putative yeast homologue, Vac1p, con-
tains a similar insertion [8]. These insertions might be impor-
tant in substrate recognition and/or in interaction with other
proteins. However, so far there are no structural data avail-
able to support this.
Based on the occurrence of other functional domains in the
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FYVE ¢nger proteins, we have divided them into 14 groups
(see Table 1 and Fig. 2). For eight of these groups, we ¢nd
putative homologues in C. elegans, while only three yeast
proteins can be matched with the human set. This suggests
that while the common function of the FYVE ¢nger has been
preserved since the origin of unicellular eukaryotes, multicel-
lular organisms have elaborated extensively their use of this
functional module. The occurrence of protein domains with
known functions related to membrane tra⁄c and PI3P metab-
olism, and the notable absence of general ‘signalling’ modules
such as SH2, SH3, GTPase and protein kinase domains sug-
gest that FYVE ¢nger proteins typically regulate ‘housekeep-
ing’ cellular functions rather than agonist-induced processes.
3. Structure of the FYVE ¢nger and its bound ligand
The structural characterisation of FYVE ¢ngers and their
interactions with ligands has advanced at a frenetic pace. Ini-
tially, the three-dimensional polypeptide fold of a FYVE ¢n-
ger was revealed by the high resolution X-ray di¡raction anal-
ysis of crystal of the FYVE ¢nger from S. cerevisiae Vps27p
[9]. The second report of the structure of a FYVE ¢nger arose
soon after in the form of the crystal structure of the tandem
VHS^FYVE ¢nger pair homodimer from the protein Hrs
from Drosophila melanogaster [10]. The results of these studies
revealed that divergent V60-residue FYVE ¢nger polypeptide
sequences adopt a conserved fold that resembles that of the
RING and PHD ¢ngers [11,12]. These are all small domains
built around a pair of antiparallel L-strands (Fig. 1, b1 and
b2) and two loops on which the four conserved Zn2-coordi-
nating CxxC motifs are placed. Like the RING ¢nger, the
FYVE ¢nger contains a C-terminal K-helix that carries one
of the coordinating cysteines. In addition, the FYVE ¢nger
contains a second pair of anti-parallel L-strands (Fig. 1, b3
and b4) that protrude from the core structure. Site-directed
mutagenesis studies have revealed that the conserved R(R/
K)HHCR sequence is a principal site of interaction with
PI3P [13,14], and the 3D structure reveals that this segment
of the chain contributes to one face of the FYVE ¢nger, along
its longest dimension, on the side opposite the C-terminal
helix.
The di¡erence between the monomeric nature of the
Vps27p structure and the dimeric Hrs FYVE ¢nger structure,
combined with crystal contacts with negatively charged
groups in lattice-neighbouring Vps27p FYVE ¢nger molecules
and bu¡er-derived citrate anions nestling in surface cavities of
the Hrs FYVE homodimer, led the crystallographers to pro-
pose con£icting models of how the inositol phosphate head-
group of PI3P would be bound, and additionally how the
FYVE ¢nger may rest at the surface of the plasma membrane
with semi-conserved hydrophobic side chains seated in the
lipid^cytosol interface (reviewed in [15]). Direct measurements
of the nature of FYVE ¢nger interactions with lipids were
provided by nuclear magnetic resonance (NMR) spectroscopic
approaches [16,17]. These reports demonstrated that for the
EEA1 FYVE ¢nger expressed on its own, there was stronger
binding to micelle-borne PI3P lipids than to soluble PI3P
headgroup mimics [16], and provided explicit evidence that
Fig. 1. Colour-coded multiple alignment of the human FYVE ¢ngers (in the absence of a good prediction of the human orthologue, murine
FGD2 is shown). Databases were searched using Blastp and Psi-Blastp [50], SMART [7], Pfam [51] and SearchWise [52]. A consensus for the
most conserved positions is shown at the top: ‘#’, strongly conserved hydrophobic; ‘^’, strongly conserved acidic; ‘+’, strongly conserved basic;
‘%’, weakly conserved hydrophobic; ‘@’, strongly conserved neutral hydrophilic. L-Strands (b1^4) and K-helices are indicated as de¢ned by the
EEA1 crystal structure (PDB entry 1JOC). Amino acid positions in the proteins are indicated in brackets. Three positions where individual pro-
teins have insertions of 10^42 residues are indicated in arrowed brackets. The colour coding is based on a full alignment of all FYVE ¢ngers
from man, yeast and Caenorhabditis elegans. This full alignment and a table with database accession numbers and additional information is
available at http://www.uib.no/aasland/fyve/. The following databases were searched: NCBI’s non-redundant protein database (http://
www.ncbi.nlm.nih.gov/blast/html/blastcgihelp.html#protein_databases) and the Sptrembl database (http://www.ebi.ac.uk/swissprot/). In some
cases the Ensembl database (http://www.ensembl.org) was searched for alternative gene predictions.
FEBS 25688 21-2-02 Cyaan Magenta Geel Zwart
H. Stenmark et al./FEBS Letters 513 (2002) 77^8478
T
ab
le
1
H
um
an
F
Y
V
E
¢n
ge
r
pr
ot
ei
ns
an
d
th
ei
r
pu
ta
ti
ve
ne
m
at
od
e
an
d
ye
as
t
ho
m
ol
og
ue
s
H
om
o
sa
pi
en
s
C
ae
no
rh
ab
di
ti
s
el
eg
an
s
S
ac
ch
ar
om
yc
es
ce
re
vi
si
ae
St
ru
ct
ur
al
fe
at
ur
es
P
ut
at
iv
e
fu
nc
ti
on
s
1
E
E
A
1
T
10
G
3.
5
N
-t
er
m
in
al
Z
F
IR
E
¢n
ge
r,
lo
ng
co
ile
d-
co
il
re
gi
on
s,
R
ab
5
bi
nd
in
g
do
m
ai
n(
s)
.
R
ab
en
os
yn
ha
s
¢v
e
N
P
F
m
ot
if
s.
F
C
C
D
1
ha
s
a
si
m
ila
r
or
ga
ni
sa
ti
on
as
E
E
A
1.
F
C
C
D
1
an
d
R
ab
ip
4
co
nt
ai
n
R
U
N
do
m
ai
ns
.
E
E
A
1,
R
ab
en
os
yn
-5
an
d
V
ac
1p
ar
e
R
ab
5
e¡
ec
to
rs
in
en
do
cy
ti
c
m
em
br
an
e
fu
si
on
[2
2,
28
,3
1]
.
R
ab
ip
4
is
a
R
ab
4
e¡
ec
to
r
in
en
do
cy
ti
c
re
cy
cl
in
g
[3
2]
.
R
ab
en
os
yn
-5
V
ac
1p
F
C
C
D
1
R
ab
ip
4
F
01
F
1.
4
E
IP
1
2
A
nk
hz
n
F
22
G
12
.4
N
-t
er
m
in
al
B
T
B
do
m
ai
n
(d
im
er
is
at
io
n
?)
,
s
15
an
ky
ri
n
re
pe
at
s.
E
nd
os
om
e^
cy
to
sk
el
et
on
in
te
ra
ct
io
ns
[5
4]
?
3
K
IA
A
09
93
(p
ar
ti
al
cl
on
e)
T
23
B
5.
2,
Y
L
N
2
W
D
re
pe
at
s
(i
m
pl
ic
at
ed
in
pr
ot
ei
n/
pr
ot
ei
n
in
te
ra
ct
io
ns
).
T
he
N
-t
er
m
in
us
of
T
23
B
5.
2
ha
s
si
m
ila
ri
ty
to
be
ig
e/
C
he
di
ak
^H
ig
as
hi
sy
nd
ro
m
e
(l
ys
os
om
al
di
so
rd
er
)
pr
ot
ei
n.
?
4
F
E
N
S-
1,
M
G
C
20
27
5
Se
ve
n
W
D
re
pe
at
s
w
it
h
F
Y
V
E
¢n
ge
r
be
tw
ee
n
re
pe
at
s
6
an
d
7.
E
nd
oc
yt
ic
tr
a⁄
ck
in
g
[4
4]
?
5
M
T
M
R
3
Y
W
91
N
-t
er
m
in
al
re
gi
on
w
it
h
si
m
ila
ri
ty
to
m
yo
tu
bu
la
ri
n,
in
cl
ud
in
g
a
P
I3
P
ph
os
ph
at
as
e
do
m
ai
n.
M
T
M
R
3
is
a
3P
-p
ho
sp
ha
ta
se
fo
r
P
I3
P
an
d
P
I(
3,
5)
P
2
.
R
eg
ul
at
es
au
to
ph
ag
y
[4
7]
?
M
T
M
R
4
F
53
A
2.
8
6
F
gd
1
C
28
C
12
.1
0
D
H
do
m
ai
n,
tw
o
P
H
do
m
ai
ns
£a
nk
th
e
F
Y
V
E
¢n
ge
r
(K
IA
A
13
62
co
nt
ai
ns
on
ly
on
e
P
H
do
m
ai
n)
.
G
E
F
fo
r
C
dc
42
,
re
gu
la
ti
on
of
ac
ti
n
cy
to
sk
el
et
on
.
F
gd
1
is
m
ut
at
ed
in
fa
ci
og
en
it
al
dy
sp
la
si
a
[3
9^
42
,5
5]
.
F
gd
2
C
33
09
.1
F
gd
3
F
ra
bi
n
K
IA
A
13
62
7
SA
R
A
D
10
22
.7
Sm
ad
-b
in
di
ng
do
m
ai
n,
T
G
F
L
re
ce
pt
or
-b
in
di
ng
do
m
ai
n.
M
ed
ia
to
r
of
T
G
F
L
si
gn
al
lin
g
[3
6]
.
A
K
A
P
C
E
re
cr
ui
ts
P
K
A
to
m
em
br
an
es
[5
6]
.
E
nd
o¢
n
(A
K
A
P
C
E
)
8
P
IK
fy
ve
C
A
A
91
79
1.
1
F
ab
1p
D
E
P
do
m
ai
n,
ch
ap
er
on
in
do
m
ai
n,
P
I3
P
5-
ki
na
se
do
m
ai
n.
P
I3
P
5-
ki
na
se
,
fo
rm
at
io
n
of
m
ul
ti
ve
si
cu
la
r
bo
di
es
(M
V
B
s)
or
m
em
br
an
e
re
cy
cl
in
g
fr
om
va
cu
ol
e/
ly
so
so
m
e
[2
4,
33
,5
7]
.
9
H
rs
C
07
G
1.
5
V
ps
27
p
N
-t
er
m
in
al
V
H
S
do
m
ai
n,
U
IM
m
ot
if
(s
),
co
ile
d-
co
il
re
gi
on
im
pl
ic
at
ed
in
ST
A
M
bi
nd
in
g,
C
-t
er
m
in
al
cl
at
hr
in
bo
x
m
ot
if
.
E
nd
os
om
e^
ly
so
so
m
e/
va
cu
ol
e
tr
a⁄
ck
in
g.
M
V
B
fo
rm
at
io
n
[2
5,
35
].
10
D
F
C
P
1
(T
A
F
F
1)
D
ou
bl
e
F
Y
V
E
¢n
ge
r
pr
ot
ei
n.
T
A
F
F
1
is
a
sh
or
te
r
sp
lic
e
va
ri
an
t
of
D
F
C
P
1.
G
ol
gi
tr
a⁄
ck
in
g
[4
4,
49
]?
11
K
IA
A
03
21
L
ar
ge
(1
54
2-
re
si
du
e)
pr
ot
ei
n
?
12
K
IA
A
16
43
L
ar
ge
(9
93
-r
es
id
ue
)
pr
ot
ei
n
?
13
M
G
C
25
50
Sm
al
l
(2
34
-r
es
id
ue
)
pr
ot
ei
n
?
14
F
L
J1
48
40
N
-t
er
m
in
al
F
Y
V
E
¢n
ge
r.
?
T
he
pr
ot
ei
ns
ar
e
di
vi
de
d
in
to
14
gr
ou
ps
ac
co
rd
in
g
to
th
ei
r
do
m
ai
n
or
ga
ni
sa
ti
on
s.
FEBS 25688 21-2-02 Cyaan Magenta Geel Zwart
H. Stenmark et al./FEBS Letters 513 (2002) 77^84 79
N-terminal loop residues insert non-speci¢cally under the mi-
celle surface. Subsequent re¢nement of this picture came in
the form of an NMR-derived solution structure of the EEA1
FYVE ¢nger bound to di-C4-PI3P [17] which provided an (at
best) medium resolution picture of the precise mode of inter-
action of the lipid headgroup phosphates and conserved ami-
no acid side chains. Nevertheless, the NMR work appears to
provide corroboration for the basic outline of the interaction
model proposed for Vps27p [9].
Greater clari¢cation of the structural biology of FYVE ¢n-
gers now required a high resolution de¢nition of the ligation
coordination of the PI3P headgroup by conserved elements of
Fig. 2. Cartoon of representative examples of the di¡erent classes of human FYVE ¢nger proteins. The Pfam (PF) or SMART (SM) accession
numbers for the di¡erent domains are given under the ¢gure key. In the case of group 3, the extent of the partial KIAA0993 sequence is
underlined, and the domain structure of the larger C. elegans homologue T23B5.2 is indicated in blue. ‘SBD’ is the SMAD-binding domain in
SARA and ‘UIM’ is the ubiquitination motif in Hrs. For further details, see Table 1 and [8].
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the FYVE ¢nger polypeptide. Satisfaction of this desire has
recently been achieved in the form of the 2.2 Aî resolution
crystal structure of a larger C-terminal segment of EEA1,
including the FYVE ¢nger and a substantial portion (40 res-
idues) of the coiled-coil dimerisation domain [18]. In this
structure each EEA1 domain of the homodimer is bound by
a molecule of inositol 1,3-bisphosphate (Ins(1,3)P2) ^ a solu-
ble mimic of PI3P. The resolution of the structure means that
this result supersedes all other attempts to model or describe
this protein^ligand interaction. It has previously been shown
that EEA1 exists as a parallel coiled-coil homodimer in cells
[19] and that although essential the FYVE ¢nger is not alone
su⁄cient for localisation to early endosomes [5,20]. Fig. 3
shows a ribbon-style representation of the EEA1 homodimer
structure (PDB code 1JOC) and gives an impression of how
the quaternary architecture is consistent with the prediction
that dimerisation ampli¢es the weak binding of individual
FYVE ¢ngers to the phospholipid ligand, and demonstrates
that the structure is ideally con¢gured for location at the £at
surface of the membrane, and apparently includes insertion of
the so-called ‘turret-loop’ residues into the membrane surface
(see Fig. 3). As shown in Fig. 4, the ligation of the PI3P
headgroup involves all the conserved signature motifs of the
FYVE domain: R(R/K)HHCR, RVC and WxxD.
4. The functions of FYVE ¢nger proteins
Yeast cells that are defective in the PI3K VPS34 are unable
to produce PI3P. The vps34 mutation causes one striking cel-
lular defect: membrane tra⁄cking from the Golgi and the
plasma membrane via endosomes to the vacuole is impaired
[21]. This suggests that, in yeast, the functions of FYVE ¢nger
proteins are concerned with endocytic/vacuolar membrane
tra⁄cking, and four out of ¢ve FYVE ¢nger proteins in
S. cerevisiae have indeed been proposed to ful¢l such a role
(the function of the ¢fth one, YGL023, has still not been
investigated). Vac1p regulates the fusion of Golgi- and plasma
membrane-derived vesicles with endosomes [22], whereas
Fab1p is a PI3P 5-kinase that controls vacuolar membrane
homeostasis and the formation of multivesicular bodies
(MVBs) [23,24]. The latter function also applies to Vps27p,
which belongs to the class E subgroup of vacuolar sorting
proteins that are thought to regulate tra⁄cking between endo-
somes and the vacuole [25]. Vps27p contains two putative
Fig. 3. Crystal structure of the EEA1 FYVE ¢nger and adjacent coiled-coil region. The homodimer nature of this structure contrasts with the
NMR observations of the isolated EEA1 FYVE ¢nger. Notably in the new structure, the dimer interface created with the coiled-coil region is
contiguous with the contact between the two FYVE ¢ngers. The two PI3P molecules are bound on a common surface directly opposite the
coiled-coil stalk and the putative arrangement of the FYVE ¢ngers on the membrane surface is more ‘prone’ than ‘end on’ as previously antici-
pated. The short linking region between the coiled-coil and FYVE ¢nger segments is structurally ordered (forming an K-helix) and residues in
this segment assist the stabilisation of the ligand coordination sphere. The interpretation of the NMR data had anticipated FYVE ¢nger dimer-
isation, but had also suggested ligand-dependent conformational changes of the FYVE ¢nger [16]. Analysis of the EEA1 crystal structure would
appear to put strict limits upon any such change, limited perhaps to a few side chain rotamer perturbations [18]. The ligation of the PI3P head-
group involves all three conserved signature motifs (see Fig. 4) [18]. The 3-phosphate is coordinated by basic side chains of the R(R/K)HHCR
and RVC motifs (interacting residues underlined) ^ the latter using a bridging water molecule. The inositol 4-OH and 5-OH/6-OH groups do-
nate H-bonds to the R(R/K)HHCR and WxxD motifs respectively. The 1-phosphate interacts with the ¢rst arginine of the R(R/K)HHCR mo-
tif. The second basic residue of the R(R/K)HHCR motif makes ‘second coordination shell’ interactions with other FYVE ¢nger residues that
reinforce the direct contacts. Interestingly, side chains involved in direct interaction with the ligand headgroup hydroxyls e¡ectively block the
locations that would be occupied by alternative ligands containing phosphates at the 4- or 5-position of the inositol ring, an observation that
goes part way to explain the ligand selectivity of the FYVE ¢nger. In all, six residues contact the Ins(1,3)P2 group, providing a detailed and
convincing rationalisation of FYVE ¢nger sequence conservation, ligand speci¢city, and the results of previously reported mutagenesis studies
[13,14]. Alternative phosphoinositide ligands would have to bind in a di¡erent orientation and would su¡er a signi¢cant reduction in binding
a⁄nity.
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ubiquitin-interacting motifs [26] and could play a role in the
sorting of mono-ubiquitinated proteins in endosomes. Vps27p
might well function downstream of Pib1p, which is an endo-
somal ubiquitin ligase that ubiquitinates target proteins [27].
It is interesting to note that yeast FYVE ¢nger proteins reg-
ulate distinct tra⁄cking steps such as membrane fusion, re-
ceptor sorting and membrane invagination, and that they act
consecutively throughout the endocytic pathway. This is con-
sistent with the localisation of PI3P on both endosomes and
vacuoles [2].
The role of PI3P and FYVE ¢nger proteins in endocytic
membrane tra⁄cking has been conserved from yeast to higher
eukaryotes. Rabenosyn-5, the mammalian homologue of
Vac1p, and the related protein EEA1 are e¡ectors of the
early-endosomal GTPase Rab5, which regulates endocytic
membrane fusion [28]. Both Rabenosyn-5, EEA1 and Vac1p
contain an N-terminal ZFIRE (zinc ¢nger in Rab e¡ectors)
¢nger, which, in the case of EEA1, has been directly impli-
cated in Rab5 binding. The exact mechanism for how Rabe-
nosyn-5 and EEA1 regulate membrane tra⁄c still remains to
be elucidated, but interactions with syntaxin-6 and syntaxin-
13, which are thought to mediate endocytic membrane fusion
through the engagement in heteromeric complexes with other
SNARE proteins, are likely to trigger endocytic membrane
tethering and fusion [29^31]. While Rabenosyn-5 and EEA1
are e¡ectors of Rab5, Rabip4 is an e¡ector of another early-
endosomal GTPase, Rab4, which regulates endocytic recy-
cling [32]. The interactions of Rabenosyn-5, EEA1 and Ra-
bip4 with di¡erent Rab GTPases could contribute to targeting
of these proteins to distinct subdomains of early endosomes.
PIKfyve is the mammalian homologue of Fab1p. This pro-
tein is localised to early endosomes and MVBs, and overex-
pression of a mutant with impaired PI3P 5-kinase activity
appears to block MVB formation [33]. Presumably, PIKfyve
regulates the invagination of endosomal membranes through
its PI3P 5-kinase activity, although the mechanism remains
obscure. The hepatocyte growth factor-regulated tyrosine ki-
nase substrate Hrs [34] is the mammalian homologue of
Vps27p. Like Vps27p it contains a ubiquitin-interacting motif,
and the C-terminus of Hrs binds to clathrin [35], suggesting
that Hrs could recruit ubiquitinated receptors into clathrin-
coated subdomains of early endosomes. This could serve to
sort receptors that are destined for late endosomes and lyso-
somes.
Besides their function in endocytic membrane tra⁄cking,
additional roles have evolved for mammalian FYVE ¢nger
proteins. The most striking example is SARA (Smad anchor
for receptor activation), which is crucial for transforming
Fig. 4. Schematic representation of the coordination of Ins(1,3)P2 (a soluble analogue of PI3P) by the conserved sequence motifs of the EEA1
FYVE ¢nger. The picture was composed from the coordinates of PDB entry 1JOC using LIGPLOT [53].
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growth factor-L (TGFL) signalling. This protein binds to both
the TGFL receptor and the downstream signalling mediator
Smad2, thus facilitating the phosphorylation (and activation)
of Smad2 by the activated receptor [36]. Both SARA and the
related FYVE ¢nger protein endo¢n are localised to early
endosomes [37], suggesting that TGFL signalling occurs
from these compartments and not from the plasma mem-
brane. It thus appears that the function of the SARA
FYVE ¢nger is to localise a signalling complex to endosomes.
Besides SARA, there is also evidence that Hrs binds to Smad2
and participates in TGFL signalling [38], but, since this pro-
tein also regulates endocytic membrane tra⁄cking, further
work is needed in order to distinguish between its roles in
TGFL receptor signalling and tra⁄cking.
In addition to the established functions of FYVE ¢nger
proteins in membrane tra⁄cking and receptor signalling, the
Fgd1 family of FYVE ¢nger proteins (see Fig. 2) appear to
regulate the actin cytoskeleton. Fgd1, which is associated with
the X-linked disease faciogenital dysplasia, is a GDP/GTP
exchange factor for the small GTPase Cdc42, which regulates
the remodelling of cortical actin [39]. Unlike most other
FYVE ¢nger proteins, Fgd1 is not associated with endosomes.
Rather, it localises to the plasma membrane, indicating that
the interaction with PI3P does not serve as a localisation
signal for this protein [39]. It is possible that two pleckstrin
homology domains that £ank the FYVE ¢nger may target
Fgd1 to the plasma membrane by binding to phosphoinosi-
tides other than PI3P. The three other members of the Fgd1
family, Fgd2, Fgd3 and Frabin, have been studied in less de-
tail than Fgd1, but preliminary results suggest that they have
overlapping functions [40^42]. Besides its atypical localisation,
Fgd1 di¡ers from other FYVE ¢nger proteins in that its
FYVE ¢nger lacks the conserved tryptophan-5, and it binds
to PI3P with low a⁄nity. Interestingly, the Fgd1 FYVE ¢nger
also binds to the structurally related phosphoinositide PI5P,
whose function is still not known [43]. Therefore, given the
lack of endosomal localisation of Fgd1, it is possible that the
Fgd1 family of FYVE ¢nger proteins may be regulated by
PI5P rather than by PI3P.
5. Conclusion
Recent progress has revealed the full array of FYVE ¢nger
proteins in humans and other organisms, and the structural
basis for the interaction of FYVE ¢ngers with PI3P has been
characterised. The proposed insertion of the hydrophobic ‘tur-
ret loop’ of the FYVE ¢nger into the membrane (Fig. 3) is
consistent with the fact that FYVE ¢ngers bind with much
higher a⁄nity to membrane-associated PI3P than to its solu-
ble analogues [14,43]. Given that PI3P is mainly found on
endosomes, it is not surprising that most FYVE ¢nger pro-
teins are associated with these organelles. However, only a few
FYVE ¢ngers (e.g. those of endo¢n and FENS-1) bind to
PI3P with su⁄cient a⁄nity to function as autonomous mem-
brane targeting domains [37,44]. In other cases (e.g. EEA1
and Hrs), additional domains are required for e⁄cient mem-
brane binding. Coiled-coil dimerisation of EEA1 may increase
its avidity for PI3P-containing endosome membranes [45], and
an interaction with Rab5 may further stabilise the interaction
or target EEA1 to Rab5-containing membrane domains. A
few FYVE ¢nger proteins (e.g. MTMR3, Fgd1 and DFCP1/
TAFF1) are not found on endosomes [39,46^49]. Presumably,
the FYVE ¢ngers of these proteins have too low a⁄nity for
PI3P to function as endosome targeting domains, and the
functional relevance of their PI3P binding remains elusive.
The functions of many FYVE ¢nger proteins have now
been studied, and the majority of these proteins serve as reg-
ulators of endocytic membrane tra⁄cking. Through evolu-
tion, a few FYVE ¢nger proteins appear to have evolved as
regulators of signalling and cytoskeletal functions. Despite
recent progress, the exact cellular functions of the FYVE ¢n-
ger proteins remain to be determined, and it will be important
to study if their interactions with PI3P play other roles in
addition to that of membrane recruitment. With the whole
set of FYVE ¢nger proteins in the human proteome available,
it should now be possible to determine the roles of these
proteins, and of PI3P, in cell biology and human disease.
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